9.63
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$10.05
Aprire:
$10.05
Volume 24 ore:
239.05K
Relative Volume:
0.49
Capitalizzazione di mercato:
$161.63M
Reddito:
$62.81M
Utile/perdita netta:
$-13.75M
Rapporto P/E:
-12.04
EPS:
-0.8
Flusso di cassa netto:
$153.00K
1 W Prestazione:
+10.18%
1M Prestazione:
+24.26%
6M Prestazione:
+88.45%
1 anno Prestazione:
-9.32%
Optimizerx Corp Stock (OPRX) Company Profile
Nome
Optimizerx Corp
Settore
Industria
Telefono
248-651-6558
Indirizzo
260 CHARLES STREET, WALTHAM, MI
Confronta OPRX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
OPRX
Optimizerx Corp
|
9.63 | 161.63M | 62.81M | -13.75M | 153.00K | -0.80 |
![]()
VEEV
Veeva Systems Inc
|
236.99 | 36.73B | 2.75B | 714.14M | 1.09B | 4.33 |
![]()
DOCS
Doximity Inc
|
59.39 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
![]()
TEM
Tempus Ai Inc
|
54.07 | 9.30B | 640.44M | -743.28M | -206.93M | -11.29 |
![]()
HQY
Healthequity Inc
|
91.42 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
40.98 | 6.34B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-01-08 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2024-12-20 | Iniziato | Stephens | Equal-Weight |
2024-07-25 | Ripresa | B. Riley Securities | Buy |
2024-04-04 | Iniziato | JMP Securities | Mkt Outperform |
2024-01-03 | Iniziato | Barclays | Equal Weight |
2023-02-02 | Ripresa | B. Riley Securities | Buy |
2022-11-01 | Iniziato | Stifel | Buy |
2022-07-15 | Iniziato | SVB Leerink | Outperform |
2021-10-18 | Ripresa | B. Riley Securities | Buy |
2021-04-13 | Iniziato | RBC Capital Mkts | Outperform |
2019-01-03 | Iniziato | William Blair | Outperform |
Mostra tutto
Optimizerx Corp Borsa (OPRX) Ultime notizie
XTX Topco Ltd Acquires New Shares in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Connors Investor Services Inc. Has $287,000 Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report - The Manila Times
Healthcare Tech Leader OptimizeRx Jumps to Elite 1st Decile in ESG Rating: Key 2025 Report Findings - Stock Titan
Geode Capital Management LLC Has $1.95 Million Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Walleye Capital LLC Acquires Shares of 138,575 OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
OptimizeRx Corp. to Host Conference Call on Q1 2025 Financial Results on May 12, 2025 - Nasdaq
OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET - The Manila Times
Healthcare Tech Leader OptimizeRx Announces Q1 2025 Earnings Call: Key Details for Investors - Stock Titan
Kennedy Capital Management LLC Increases Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Analysts Set OptimizeRx Co. (NASDAQ:OPRX) Target Price at $9.06 - MarketBeat
OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment - The Manila Times
Whetstone Capital Advisors LLC Invests $6.56 Million in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Co. (NASDAQ:OPRX) Short Interest Up 22.0% in March - MarketBeat
Is OptimizeRx Corporation (NASDAQ:OPRX) Expensive For A Reason? A Look At Its Intrinsic Value - simplywall.st
Blair William & Co. IL Reduces Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Co. (NASDAQ:OPRX) Sees Significant Increase in Short Interest - Defense World
OptimizeRx Corporation (NASDAQ:OPRX) is favoured by institutional owners who hold 59% of the company - Yahoo Finance
Bank of New York Mellon Corp Has $426,000 Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Files $75 Million Mixed Shelf - Marketscreener.com
OptimizeRx Corp Files For Mixed Shelf Of Up To $75 MillionSEC Filing - MarketScreener
OptimizeRx Co. (NASDAQ:OPRX) Director James Paul Lang Purchases 321,408 Shares - MarketBeat
Royce & Associates LP Takes Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Corp (NASDAQ: OPRX): The Metrics That Matter Right Now - Stocks Register
OptimizeRx Co. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
OptimizeRx Corp SEC 10-K Report - TradingView
OptimizeRx director James Lang purchases $2.44 million in common stock - Investing.com Australia
OptimizeRx director James Lang purchases $2.44 million in common stock By Investing.com - Investing.com South Africa
OptimizeRx (OPRX) to Release Quarterly Earnings on Wednesday - MarketBeat
Q1 Earnings Forecast for OptimizeRx Issued By B. Riley - MarketBeat
Head to Head Review: OptimizeRx (NASDAQ:OPRX) & CFN Enterprises (OTCMKTS:CNFN) - Defense World
Why OptimizeRx Corp. (OPRX) Soared Last Week? - Insider Monkey
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates - MSN
Roth Capital Predicts OptimizeRx's Q1 Earnings (NASDAQ:OPRX) - MarketBeat
Research Analysts Issue Forecasts for OptimizeRx Q1 Earnings - Defense World
OptimizeRx (NASDAQ:OPRX) Releases Earnings Results, Misses Expectations By $0.11 EPS - MarketBeat
OptimizeRx (NASDAQ:OPRX) Upgraded at B. Riley - MarketBeat
OptimizeRx Corp [OPRX] CEO makes an insider purchase of 20,000 shares worth 0.1 million. - Knox Daily
Optimizerx Corp Azioni (OPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):